During this phase, continuing the medication while potentially increasing activity or refining nutritional choices often reignites progress
The Wegovy injection is approved for people aged 12 and up
Related products More in Metabolic & GLP-1 Research Other research peptides in the same category
They are commonly used by patients who: They work best when combined with: Lipotropic compounds assist the liver in breaking down fat and optimizing metabolic processes
GLP-1 Side Effects The use of GLP-1 receptor agonists, while beneficial for weight management, can sometimes come with side effects
Some patients may experience serious adverse reactions: acute pancreatitis (symptoms include persistent severe abdominal pain, sometimes radiating to the back and accompanied by vomiting), hypoglycemia, renal impairment (which may sometimes require hemodialysis)